Quote:
Originally Posted by SupDock
A small risk with both that becomes a bigger risk when combined.
I would be astonished if we see significant outpatient prescribing of this combination in the near future.
|
That risk is still ridiculously small.
I sincerely hope you are wrong. For the sake of argument let's say it is limited to inpatient care use only. Now, let's say it has 80% effectiveness in a 6 day span. At that point ,given that supply is not an issue, and it should not be at that point in time or slightly beyond, would you be ok with business as usual (with certain conditions that I pointed out) starting April 1st?
If not why not?